Mind Medicine (MindMed) Inc at RBC Capital Markets Global Healthcare Conference Transcript
Okay. Good afternoon, everyone. I'm Brian Abrahams, one of the senior biotech analysts here at RBC Capital Markets. Our last presenting company of the day is MindMed represented by their CEO, Rob Barrow. Rob, thanks so much for joining us.
()-
Thank you.
So let's start bigger picture. The psychedelic field has received a significant amount of interest lately. What drives your approach at MindMed and where do you see yourself as being most differentiated? And I'm thinking with respect to your asset itself, the indication, and indications you're going to be looking at, and your administration of such?
Questions & Answers
()-
Yeah, absolutely. I've had the good fortune of working with a number of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
